Background. High-risk human papilloma virus (hrHPV) testing was added to the cytology
triage of women with equivocal screening smears in the Norwegian programme for cervical …

Introduction In randomized studies, testing for high‐risk (HR) human papillomavirus (hrHPV)
has been more sensitive than conventional cytology in detecting cervical intraepithelial …

Introduction Since 2012, cervical cancer screening has been conducted with a primary high‐
risk human papillomavirus (hrHPV) test and conventional cytology triage in the city of …

Background Randomised controlled trials showed human papillomavirus (HPV)-based
screening leads to a significant reduction in cervical cancer incidence compared with …

Objectives To compare the short-term and long-term effectiveness of human papillomavirus
(HPV) tests in Norwegian Cervical Cancer Screening Programme (NCCSP). Design …

AIM:: To determine cross-sectional validity of primary human papillomavirus (HPV)
screening in comparison to cytological screening. METHODS:: During 2003–2004, 61,149 …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Objective To compare primary test positivity in cytology and human papillomavirus-based
screening between different Nordic cervical cancer screening programs using harmonized …

We compared test sensitivity (in terms of prevented cancers) and overdiagnosis (in terms of
non‐progressive pre‐invasive lesions) between the human papillomavirus test (HPV test …

Background Cervical cytology has been the primary method of cervical cancer screening for
decades. Tests that detect viral HPV are shown in several randomized trials to provide better …